DOJ-OGR-00006331.jpg

Case 1:20-cr-00330-PAE Document 431 Filed 11/09/21 Pagelof2 USpc SDNY UNITED STATES DISTRICT COURT sania | SOUTHERN DISTRICT OF NEW YORK ar ec eacetiaemeent DOCK DATE FILED: 11/9/21 United States of America, _y_ 20-CR-330 (AJN) Ghislaine Maxwell, ORDER Defendant. ALISON J. NATHAN, District Judge: As noted in its previous Order, the Court will hold an in-person proceeding on November 10, 2021 at 9:00 a.m. Dkt. No. 409. The proceeding will take place in Courtroom 110 of the United States District Court for the Southern District of New York, Thurgood Marshall U.S. Courthouse at 40 Foley Square, New York, New York. The purpose of the proceeding is to address the Defendant’s motion under Federal Rule of Evidence 412, Dkt. No. 378, the Defendant’s motion in limine to exclude under Federal Rule of Evidence 702 and Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), Dkt. No. 386, and the other outstanding issues that overlap with these two motions as discussed at the November 1, 2021 conference. As is expressly required by Federal Rule of Evidence 412, the Court must conduct a hearing on this motion in camera and seal the record of the hearing. Fed. R. Evid. 412(c)(2). Accordingly, this portion of the hearing will be sealed and in camera. The Government confirmed that the attorneys for the alleged victims implicated by the Defendant’s motion have been notified of their right to attend the hearing pursuant to Federal Rule of Evidence 412. Dkt. No. 430. For the public portions of the proceeding, the Court will ensure access for alleged victims and any members of the Defendant’s family, in accordance with its prior Order. Dkt. No. 344. 1 DOJ-OGR- 00006331